| Minal Doshi, MD | |
|
254 Easton Ave, New Brunswick, NJ 08901-1766 | |
| (732) 339-7870 | |
| Not Available |
| Full Name | Minal Doshi |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology |
| Location | 254 Easton Ave, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346506193 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0402X | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology | 25MA09662100 (New Jersey) | Primary |
| Entity Name | Saint Peters University Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114924834 PECOS PAC ID: 9931012382 Enrollment ID: O20040112000043 |
News Archive
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Do you know if your labs are providing the appropriate evidence-based care? Can you uncover root causes beneath changes in volume and outcome patterns? Can you track whether your heart program is slowing or growing, profitable or not? LUMEDX healthcare analytics can help.
Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.
› Verified 1 days ago
| Entity Name | Saint Peter's Healthcare System Physician Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548569361 PECOS PAC ID: 9537337258 Enrollment ID: O20110725000726 |
News Archive
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Do you know if your labs are providing the appropriate evidence-based care? Can you uncover root causes beneath changes in volume and outcome patterns? Can you track whether your heart program is slowing or growing, profitable or not? LUMEDX healthcare analytics can help.
Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.
› Verified 1 days ago
| Entity Name | Saint Peter's Specialty Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861894982 PECOS PAC ID: 8426373952 Enrollment ID: O20150204001582 |
News Archive
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Do you know if your labs are providing the appropriate evidence-based care? Can you uncover root causes beneath changes in volume and outcome patterns? Can you track whether your heart program is slowing or growing, profitable or not? LUMEDX healthcare analytics can help.
Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Minal Doshi, MD 254 Easton Ave, New Brunswick, NJ 08901-1766 Ph: (732) 339-7896 | Minal Doshi, MD 254 Easton Ave, New Brunswick, NJ 08901-1766 Ph: (732) 339-7870 |
News Archive
Every day, more than 20 percent of the U.S. population experiences the painful burning symptoms of gastroesophageal reflux disease (GERD). For these 20 million Americans, the first line of defense is medication. To find a long-term, permanent solution for this nagging condition, the Center for the Future of Surgery at UC San Diego Medical Center is leading a multicenter clinical trial to test the safety and effectiveness of a new incisionless GERD treatment.
ViroPharma Inc. has announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Cinryze C1 Inhibitor (human) as a treatment for acute attacks of hereditary angioedema (HAE).
Do you know if your labs are providing the appropriate evidence-based care? Can you uncover root causes beneath changes in volume and outcome patterns? Can you track whether your heart program is slowing or growing, profitable or not? LUMEDX healthcare analytics can help.
Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.
› Verified 1 days ago
Janti Chaaban, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 254 Easton Ave, Pediatric Neurology, New Brunswick, NJ 08901 Phone: 732-745-8600 | |
Shelly Rishty, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St Ste 6100, New Brunswick, NJ 08901 Phone: 732-235-7733 | |
Carlos Lastra, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-339-7870 Fax: 732-745-1632 | |
Dr. Emad Nourollah-zadeh, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Robert Wood Johnson University Hospital, 125 Paterson Street,, New Brunswick, NJ 08901 Phone: 732-235-7041 | |
Shan Chen, MD, PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St, Suite 6100, New Brunswick, NJ 08901 Phone: 732-235-7733 Fax: 732-235-7041 | |
Dr. Susan F Janes, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 11 Bishop Pl, New Brunswick, NJ 08901 Phone: 732-932-7402 Fax: 732-932-1223 | |
Lawrence I Golbe, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 125 Paterson St, Suite 6100, New Brunswick, NJ 08901 Phone: 732-235-7733 Fax: 732-235-7041 |